logo
Plus   Neg
Share
Email

Imperial Brands To Sell Worldwide Premium Cigar Business For €1.23 Bln; Stock Up

Shares of Imperial Brands plc. (IMB.L,IMBBF.PK,IMBBY.PK) were gaining around 4 percent in the morning trading in London after the tobacco company announced Monday that it has agreed the sale of its worldwide premium cigar businesses for 1.23 billion euros or 1.07 billion pounds.

The disposals are expected to realise net cash proceeds of around 1.09 billion euros or 958 million pounds. The proceeds will be used for debt reduction.

The Premium Cigar business contributed 80 million pounds of profit before tax in the year 2019.

The sale will be completed in two distinct transactions. Gemstone Investment Holding Ltd will acquire Premium Cigar USA for a total consideration of 185 million euros.

Allied Cigar Corp. S.L will acquire Rest of the World business, Premium Cigar RoW, for a total consideration of 1.04 billion euros.

The transactions are expected to close in the third quarter of calendar year 2020. The Premium Cigar RoW transaction includes the sale of the Dominican Republic handmade premium cigar factory which is expected to close in 2021.

Joint Interim Chief Executives Dominic Brisby and Joerg Biebernick said, "This disposal reinforces our strategic ambition of becoming a leaner and more agile organisation and the proceeds will realise value for shareholders by reducing debt as part of our ongoing focus on active capital management."

In London, Imperial Brands shares were trading at 1,601.90 pence, up 3.58 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Volkswagen Group were gaining around 3 percent in German trading after the automotive giant Thursday reported market recovery in the third quarter with improved deliveries in the month of September. For the first nine months of fiscal 2020, the company, meanwhile reported sharply lower earnings with weak revenues and sales volume. Comcast Corp. on Thursday reported a 37 percent decline in profit for the third quarter from last year, hurt primarily by revenue decline at NBCUniversal. Both adjusted earnings per share and quarterly revenues topped analysts' expectations. The company also declared a quarterly dividend. In the pre-market trade, CMCSA is trading at $42.83, up $0.85 or 2.02 percent. Regeneron announced positive results from its late stage COVID-19 outpatient trial, indicating that its antibody cocktail therapy significantly reduced virus levels and need for further medical attention. The trial results showed that investigational antibody cocktail, REGN-COV2, met the primary and key secondary endpoints.
RELATED NEWS
Follow RTT